▲ Up
 
00:49 28-04-2017
MAIN АКИpress CA-News
ADVERTISE WITH US SUBSCRIBE
KazakhstanKyrgyzstanMongoliaTajikistanTurkmenistanUzbekistanWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
U.S. Food and Drug Administration approves at home heroin-antidote
15:17, 04 April 2014, 762

AKIPRESS.COM - Evzio The U.S. Food and Drug Administration has approved a device that reverses the effects of overdoses from opioids, including heroin and prescription painkillers, The Voice of Russia reported.

Opioids include legal prescription painkillers, such as OxyContin and Vicodin, as well as illegal drugs like heroin.

Called Evzio, the emergency treatment works like the well-known EpiPen – an auto-injector for serious allergic reactions – it is injected into the muscle and does not require training. Evzio administers the drug naloxone that has long been used in ambulances and emergency rooms to treat opioid overdoses. Now Evzio allows caregivers, family members and non-medical personnel to keep naloxone on hand, in a pocket or a medicine cabinet. The device requires a prescription. The FDA said Evzio's design makes it easy for anyone to administer. Once Evzio is turned on, it provides verbal instructions and is about the size of a credit card or small cellphone.

It comes in a kit that costs about $60. With a shelf life of two years, every kit has two pre-filled syringes of the drug, along with other items to help use it safely.

Naloxone is effective because it reverses the slowed-down breathing that leads to death during an overdose, Douglas Throckmorton, deputy director for regulatory programs with the FDA's Center for Drug Evaluation and Research, said.

If someone is given naloxone who is not overdosing from an opioid, the dose available in the Evzio device will not hurt them, Throckmorton added.

However, Evzio is not a substitute for immediate medical care, the FDA says.

More than 16,000 people died in the U.S. in 2010 due to opioid-related overdoses, driven largely by prescription drug overdoses, according to the Centers for Disease Control and Prevention.


Full access to all news articles in English

1 month2000 somsubscribe
year20000 somsubscribe
These subscription fees are for private individuals only. Please contact us via phone +996 (312) 900-776 or email info@akipress.org for corporate subscription inquiries
Twitterfacebookprint
LATEST NEWS
18:00 Quiz — Can you guess Kyrgyzstani politicians' spouses?17:53 Tajikistan develops national road safety strategy17:46 Foreign Minister of Uzbekistan, EU Special Representative for Central Asia review cooperation17:30 Traffic rule-brakers' cars will be evacuated from Apr. 29 — Police17:13 Interior Minister: Parents of high-profile hit-and-run driver asking parents of injured school boys to renounce their claims17:03 Kyrgyzstan, Uzbekistan define 76.5% of total state border — PM Jeenbekov16:59 Honorary Consulate of Kazakhstan opens in India's Chennai16:55 First forum of cultures kicks off in Bishkek16:42 e-Government to start fully working from July16:38 9 out of 18 Chinese companies that supplied poultry meat to Kyrgyzstan in 2016 do not exist16:37 Government of Kyrgyzstan plans to equate civil servants' salaries16:32 At least 10 top Tajik anticorruption officials arrested16:16 Implementation of "Safe School" program requires 45 bln som — Ministry of Education of Kyrgyzstan16:16 Kazakhstan to join Hague Conference on Private International Law15:59 Road construction cost higher in Kyrgyzstan than in US or Europe: Ex-head of Accounts Chamber15:53 State Border Service of Kyrgyzstan seeks to buy service dogs for 0.5 mln som15:47 Kyrgyzstan's Dastan Sharsheyev vs Russia's Anton Kalinin set for rematch15:46 Only 6 our of 166 state-run companies bring profit: MP15:37 PM blames undeveloped industry for low GDP per capita in Kyrgyzstan compared to neighbors15:09 President's Office suggests to create state tourism company
© AKIpress News Agency - 2001-2017. All rights reserved
Republication of any material is prohibited without a written agreement with AKIpress News Agency. Any citation must be accompanied by a hyperlink to akipress.com.
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75